Virtu Financial LLC Mereo Biopharma Group PLC Transaction History

Virtu Financial LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$2.58 - $4.25 $36,512 - $60,146	14,152 New	14,152 $51,000
Q4 2023 Feb 26, 2024	SELL	$1.19 - $2.42 $16,387 - $33,325	-13,771 Reduced 40.39%	20,322 $47,000
Q3 2023 Nov 14, 2023	BUY	$1.15 - $1.67 $39,206 - $56,935	34,093 New	34,093 $44,000
Q4 2022 Feb 15, 2023	SELL	$0.5 - $1.01 $7,067 - $14,276	-14,135 Reduced 41.72%	19,745 $15,000
Q3 2022 Nov 07, 2022	BUY	$0.82 - $1.73 $27,781 - $58,612	33,880 New	33,880 $29,000
Q1 2022 May 17, 2022	SELL	$1.04 - $1.7 $65,566 - $107,176	-63,045 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$1.51 - $2.59 $76,772 - $131,683	50,843 Added 416.68%	63,045 $101,000
Q3 2021 Nov 12, 2021	BUY	$2.2 - $3.17 $26,844 - $38,680	12,202 New	12,202 $30,000
Q1 2021 May 19, 2021	SELL	$2.6 - $4.43 $155,911 - $265,649	-59,966 Closed	0 $0
Q4 2020 Feb 24, 2021	BUY	$1.95 - $3.6 $116,933 - $215,877	59,966 New	59,966 $215,000

107M

209K

479K

Ticker MREO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,986,000
Market Cap $440M
Description
Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.